Literature DB >> 910945

Blood-brain amino acid transport and content during anoxia and reoxygenation.

L R Drewes, W P Conway, D D Gilboe.   

Abstract

The isolated dog brain preparation was used to investigate the dynamics of cerebral amino acid metabolism during perfusion with anoxic blood (PO2 less than 10 mmHg). Significant uptake of histidine and lysine, as determined by arteriovenous (A-V) differences in whole blood samples, was observed during 30 min of cerebral anoxia. The A-V differences determined from plasma samples indicated that uptake of histidine and efflux of glutamic acid and proline had occurred. Nitrogen balance in the preparation appeared to be maintained. Thirty minutes of anoxic perfusion resulted in increased tissue concentrations of five essential amino acids (methionine, histidine, leucine, lysine, and valine) and a decreased tissue level of the essential amino acids threonine and phenylalanine. Taurine, gamma-aminobutyric acid, alanine, glycerophosphoethanolamine and phosphoethanolamine also increased, whereas the aspartic acid concentration declined. When aerobic perfusion was resumed, the total pool of essential amino acids continued to increase and was nearly twice normal after 120 min of reperfusion. The combined concentration of asparagine and glutamine, serine, alpha-aminobutyric acid, and cystathionine also increased during postanoxic perfusion. Only taurine and phenylalanine concentrations returned toward normal.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910945     DOI: 10.1152/ajpendo.1977.233.4.E326

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Astrocytic amino acid metabolism under control conditions and during oxygen and/or glucose deprivation.

Authors:  Leif Hertz
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

2.  Identifying hypoxia in a newborn piglet model using urinary NMR metabolomic profiling.

Authors:  Christopher Skappak; Shana Regush; Po-Yin Cheung; Darryl J Adamko
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.